The P2X7 is an adenosine triphosphate (ATP)-gated ion channel involved in several facets of immune activation and neuronal function through its importance in interleukin (IL)-1β secretion. We hypothesized that blockade of P2X7 would prevent perinatal brain injury associated with exposure to intrauterine (IU) inflammation. Dams received 45 mg/kg of Brilliant Blue G (BBG), a specific P2X7 receptor (P2X7R) antagonist, on gestation day 17 (E17) prior to administration of lipopolysaccharide (LPS) or phosphate-buffered saline (PBS). Furthermore, we utilized embryo transfer experiments to delineate whether the P2X7 was the key mediator of IU inflammation-associated brain injury on maternal or fetal sides. In these experiments, P2X7
Introduction
Over 70% of perinatal mortality can be attributed to preterm birth. Additionally, preterm birth significantly increases risk for acute and chronic morbidity in developed countries and continues to pose a significant challenge for perinatal medicine [1] [2] [3] [4] . Up to 40% of preterm births are associated with intrauterine inflammation [5] [6] [7] . Prenatal exposure to intrauterine infection and inflammation are known risk factors for fetal neuronal injury and adverse neurodevelopmental outcomes in offspring [8] [9] [10] [11] [12] [13] [14] . Elevated levels of proinflammatory cytokines likely contribute to the adverse neurological outcomes following fetal neuroinflammation [15] [16] [17] . As the fetal brain develops, the inflammatory insult can lead to severe long-term neurologic conditions such as cerebral palsy, schizophrenia, autism, and a spectrum of cognitive insults [18] [19] [20] [21] .
Animal models have been used to recapitulate elements of human disease, including maternal inflammation, preterm birth, and offspring sequelae [22] [23] [24] [25] [26] [27] . In animal models of intrauterine inflammation employing lipopolysaccharide (LPS), a toll-like receptor (TLR)-4 agonist, offspring acquired behavior and motor disorders similar to those affecting preterm children [11, 13, 22, 23, [27] [28] [29] . The response to maternal inflammation is marked by increased expression of proinflammatory cytokines, such as interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α in placental and fetal tissues [30] [31] [32] . As a master regulator of inflammation, IL-1β is increasingly recognized as a major contributor to perinatal brain injury [33] [34] [35] .
In fetal brain development subject to injury, IL-1β increase is produced by immune cells such as macrophages and microglia. Expression of IL-1β is a highly regulated process, requiring TLR signaling [36] [37] [38] [39] [40] . The release and secretion of IL-1β are dependent on extracellular ATP-induced activation of a purigenic-gated potassium channel, P2X7 [41, 42] . Brilliant Blue G (BBG) is a P2X7 Receptor (P2X7R)-specific inhibitor that can block LPS-induced IL-1β release [43, 44] . In animal models of adult neuronal injury, BBG was shown to be neuroprotective with reduced activation of astrocytes and microglia and decreased cytokine expression [45] [46] [47] .
IL-1β may be the predominant mediator of perinatal brain injury [29] . Furthermore, a systemic administration of IL-1 has been shown to induce preterm labor in mice, defined as embryonic day less than 18.5 [48] . In the current study, we employed a pharmacologic blockade using BBG acting on the P2X7 receptor to inhibit IL-1β signaling and surveyed fetal brain architecture including dendrites per neuron quantitation by immunohistochemical assessment and subsequent imaging. We assessed whether the BBG blockade effect persisted neonatally by preventing neuronal cortical injury with Nissl staining and cortical neuron counts. Using behavioral testing, we confirmed that these morphologic differences translated into behavioral aberrations in preweaned neonatal mice. For an additional biological approach, we utilized an embryo transfer model to examine the effect of intrauterine inflammation with maternal or fetal loss of IL-1β secretion in response to LPS to determine whether the maternal or fetal contribution of the proinflammatory cytokine is essential for neuronal insult. The embryo transfer model was also used to survey the differences in immunologic gene expression at the level of the placenta and determine its contribution to intrauterine inflammation.
Materials and methods

Mouse model of intrauterine inflammation
All animal care and treatment procedures were approved by the Animal Care and Use Committee of Johns Hopkins University and conform to The Society for the Study of Reproduction (SSR) guidelines and standards. Timed-pregnant wild-type(WT) mice were obtained from Charles River Laboratories (Wilmington, MA), and an established model of intrauterine inflammation was used as previously described [9] [10] [11] 13, 22, 23, 25, 49] . Briefly, pregnant dams underwent laparotomy at embryonic day 17 (E17) and were injected with 25 μg LPS (from E. coli O55:B5) (Sigma-Aldrich, St Louis, MO) in 100 μl phosphate-buffered saline (PBS) or 100 μl of PBS vehicle between the first and second embryos of the right uterine horn. For BBG treatment, dams received 45 mg/kg BBG in 500 μl PBS intraperitoneally (IP) 1 h before surgery. The dose of BBG was selected based on reports by others [45, 50, 51] .
Immunohistochemistry
Fetal brains were harvested 6 h after LPS exposure on embryonic day 17.5. Using a sterile technique, the cortex was separated from the meninges, brainstem, and cerebellum and placed in a neurobasal medium containing 0.03% trypsin (Invitrogen). The sample was incubated for 15 min at 37
• C. Brain tissue was removed and placed in a neurobasal medium of 10% fetal bovine serum and was allowed to settle so as inactivating trypsin. Subsequently, the medium was replaced with a neurobasal medium supplemented with B-27 vitamin and 0.5 mmol/l of L-glutamine. This particular combination of media selectively allows growth of neurons, leaving out glia [10] . Neurons were stained with anti-mouse microtubule-associated protein 2 (MAP2) antibody to identify dendrites and cell bodies. Images were acquired with a Zeiss Axioplan fluorescence microscope. Images were analyzed, and dendrites were quantified using Image J (NIH, Bethesda, MD). We performed immunohistochemical staining of fetal brain and placenta using P2X7R antibodies (Sigma-Aldrich).
The placenta sample showed high levels of P2X7R at the chorionic plate with LPS inducing a stronger expression (Supplementary Figure 1) .
Nissl staining of neonatal neuronal morphology
Mice were sacrificed E17 and cortical tissue was isolated and subdivided into sections, which were allowed to dry. The tissue was then dipped in the Nissl stain (cresyl violet 0.1%, Sigma-Aldrich) for 5 min. The sections were then briefly rinsed in water and sequentially dipped in 70% ethanol for 1 min and 95% ethanol for an additional minute. The treatment then consisted of differentiation in 1% glacial acetic acid (Sigma-Aldrich) in 95% ethanol for 5 min, which was allowed to dehydrate in 100% ethanol for a total of 10 min over 2 cycles. The tissue was then cleared with Hemo-DE (Sigma-Aldrich) three times for 3 min intervals and mounted with DPX mounting medium (Sigma-Aldrich).
Neonatal behavioral milestone assessment
To determine the impact of LPS exposure and treatment on neuromotor and cognitive development, we used established developmental milestone tests. On postnatal day (PND) 5, PND 9, and PND 13, offspring were assessed for coordination (negative geotaxis) and strength (cliff aversion) for preweaning neurodevelopment. The negative geotaxis test measured the ability to turn 180
• when placed head down on a 45
• inclined surface. The cliff aversion test measures the ability of the mouse to turn and crawl away from an edge [11, 52] . The amount of time to complete each test was recorded and analyzed. A total of 25 litters (n = 6 PBS, 5 LPS, 5 BBG+NS, and 9 BBG+LPS) were analyzed.
Adoptive embryo transfer
For blastocyst collection, female WT (Charles River Laboratories) or P2X7R -/-(referred to as DEF for deficient or KO for knockout;
The Jackson Laboratory, Bar Harbor, ME) mice were superovulated by IP injection of 5 international units (IU) pregnant mare serum gonadotropin (National Hormone and Peptide Program, Torrance, CA) on day 1 and 5 IU human chorionic gonadotropin (hCG) (SigmaAldrich) on day 3. Females were mated with syngeneic males on day 3 immediately after hCG injections. Mating was confirmed by the presence of copulation plugs on day 4, counted as E0.5 of embryonic development. Pseudopregnancy was induced in recipient females by mating with vasectomized males. Embryos from donor females were collected and injected into the oviducts of the pseudopregnant recipient females. P2X7R −/− mice (dams or embryos) lack the P2X7 receptor and, therefore, are unable to release IL-1β in response to inflammatory stimuli. We used variations of the embryo transfer model to perform immunohistochemistry and generate images of cortical neurons that were analyzed by dendrite counts using Image J (NIH, Bethesda, MD).
Microarray analysis of gene expression and immunocard quantitative polymerase chain reaction (qPCR) data
RNA was prepared from fetal brains and placenta harvested 6 h after surgery using RNEasy Plus Mini Kit (Qiagen, Valencia, CA). The RNA samples from fetal brain were amplified and labeled with the Ambrion WT Expression kit following manufacturer's protocol (Life Technologies). Hybridization onto Affymetrix Mouse Gene 1.0 ST microarrays for 17 h at 45
• C and scanning the Affymetrix GeneChip Scanner 3000 7G, were performed as per manufacturer's protocol (Affymetrix Inc., Santa Clara, CA). Scanning and raw analysis were performed with Expression Command Console 1.2 (Affymetrix). Data were extracted with Genomics Suite 6.6 (Partek, St Louis, MO) using robust multi-array average normalization and log transformed for quality control and further analyses. Student's t-test was used to compare gene expression between LPS and PBS treatment groups for WT, embryo transfer, and P2X7R −/− mutants. The placenta RNA samples were then converted to cDNA and immunocards using a qPCR platform were performed (Qiagen, Valencia, CA) to evaluate for various inflammatory markers. Student's t-test was utilized to compare relative expression levels. Genes with significant foldchange in expression (P < 0.05) were analyzed. 
Statistical analysis
All data were tested for normality prior to analysis. Behavioral data are presented as mean ± Standard error of the mean. The qPCR C T data were log transformed prior to analysis. For parametric data, outliers were identified using Grubb outlier test. The Student's t-test or one-way analysis of variance (ANOVA) with Bonferroni post hoc tests were used. For nonparametric data, Mann-Whitney or Kruskal-Wallis with Dunn multiple comparisons tests were used. Results with a P < 0.05 were considered significant.
Results
Introduction of Brilliant Blue G improved preterm birth rate in an intrauterine inflammatory environment
In utero LPS treatment elicited a preterm birth rate of 75% in dams, as expected. However, preterm birth rate was reduced by 44% with BBG treatment. These data suggested that P2X7R blockade created a clinically favorable outcome by curtailing preterm birth rates (Table 1) .
P2X7R blockade protected against fetal cortical neuronal injury
To assess fetal cortical brain injury, we performed in vitro cortical neuron culture assays and determined the number of dendrites per neuron as previously described in the maternal injection model [29] . Immunohistochemical staining revealed decreased growth, dysmorphic cell bodies, overall decrease in MAP2 staining, and lack of cellular aggregation. The impairment of dendrite growth in neurons from LPS-exposed pups (Figures 1A-C) was partially ameliorated by BBG pretreatment including preservation of cell body, axonal projections, and dendrite arborization ( Figure 1D ). Quantification of cortical neuron dendrites showed an impairment of dendrite formation in LPS-exposed pups compared to PBS controls for which pretreatment with BBG ameliorated this deficit ( Figure 1E ) (P < 0.001).
P2X7 blockade by Brilliant Blue G prevented intrauterine lipopolysaccharide -induced changes to cortical neuronal structure in the neonatal period Nissl staining suggested that BBG co-administered with LPS attenuated the aberrations produced by LPS (Figure 2 A-D) . The neurons in the LPS group showed a marked decrease in overall survival, loss of cytoplasmic basophilia, and overall lack of aggregation. Neuron counts and deleterious effects of an LPS environment were attenuated, when BBG was administered ( Figure 2E ). These data suggested that the effect of BBG persisted into the neonatal period. Brilliant Blue G-mediated P2X7R blockade prevented intrauterine lipopolysaccharide -induced preterm birth and improved adverse preweaning neurodevelopment outcomes
In previous studies, we have shown an impairment of neurodevelopment and neuromotor test performance in preweaning offspring exposed to intrauterine inflammation [11] . To evaluate the role of IL-1β, we tested offspring exposed to both BBG and LPS in utero. Affected pups had significant deficits in negative geotaxis performance at PND 13 and cliff aversion at PND 5 and 13 compared to offspring from PBS-treated dams (P < 0.05; Figure 3 ). Administration of BBG prior to LPS exposure significantly reduced the adverse behavior effect postnatally, suggesting a functional improvement in neurodevelopment.
Maternal interleukin-1β deficiency protected against fetal neuronal injury while maternal interleukin-1β competency leads to fetal neuronal damage
Next, an embryo transfer model was used to investigate the respective contribution of maternal and fetal P2X7R signaling to fetal neuronal injury. By controlling the P2X7R receptor status of both the mother and embryo, we were able to evaluate the relative downstream neonatal gene expression effects secondary to LPS exposure. WT (P2X7R +/+ ) dams received embryos with a null (P2X7R −/− ) genotype. Conversely, embryos with a P2X7R +/+ genotype were transferred to P2X7R −/− dams. As expected, the LPS-exposed pups had a significantly reduced number of dendrite counts per neuron, an effect that was almost completely abolished by the addition of BBG (Figure 4, lane 3) . The embryo transfer (ET) model allowed us to probe the mechanism responsible for the fetal neuronal injury. Notably, the P2X7 knockout in both dam and pup preserved dendrite counts following LPS treatment (Figure 4, lane 4) . The Dam KO Pup WT genotype showed neuronal damage and low dendrite counts, albeit better, but consistent with our LPS control ( Figure 4 , lane 5). WT fetuses gestating in knockout dams witnessed a relative preservation of dendrite counts, while knockout pups gestating in WT dams sustained the most significant neuroanatomic damage.
Microarray data from the knockout pups derived from wild-type dams suggested a gene expression profile of male-biased genes in the sexually dimorphic gene expression pattern
To further explore the requirements for the neuronal phenotype, microarray data from fetal cortex RNA samples in the embryo transfer model were analyzed by qPCR. Shown are expression levels with significant changes in gene expression of LPS versus PBS exposure ( Figure 5 ). In the WT dams and pups, we observed upregulation of oogenesin 1 (Oog1), DAZ interacting zinc finger 1 (Dzip1) and TD and POZ domain containing 5 (Tdpoz5) genes, quintessential in early embryogenesis ( Figure 5 , dam WT pup WT). The Oog1 gene functions in oogenesis and fertilization in early embryogenesis [53] . Similarly, the Dzip1 gene works in spermatogenesis and primary ciliary formation [54] . In contrast, the Tdpoz1 gene is implicated in nuclear scaffolding and transcription regulation in pre-implantation embryos [55] .
In the mutant dams and pups, we observed increased expression of the following genes: ectonucleotide pyrophosphatase/phosphodiesterase 4 (Enpp4), ubiquitin-like modifier activating enzyme 6 (Uba6), and X-linked inhibitor of apoptosis (XIAP)-associated factor 1 (Xaf1) ( Figure 5 , Dam KO Pup KO). The Enpp4 gene is involved in innate immune system formation and platelet aggregation at nascent thrombi. The Uba6 is a known activator of ubiquitin by creating a thioester bond with Fat10 in the presence of proinflammatory conditions [56] . In the same vein, Xaf1 is involved in activation of TNFα-induced apoptosis of trophoblast cells by direct inhibition of anticaspase [57] . In the knockout pups derived from WT dams, we observed a substantial upregulation of RIKEN cDNA C030026M15 (C030026M15Rik), DEAD-box helicase 3 Y-linked (Ddx3y), ubiquitously transcribed tetratricopeptide repeat containing Y-linked (Uty), lysine-specific demethylase 5D (Kdm5d), and eukaryotic translation initiation factor 2 subunit 3 Y-linked (Eif2s3y) genes (Figure 5 , dam WT pup KO). These genes are thought to be Y-linked paralog genes, which function in male-biased expression of various brain regions in the study of sexual dimorphic gene expression in the brain [58] .
Placental global gene expression favored a proinflammatory environment showing that it was the placental interface that modulated immunologic balance (Table 2) The immunocard qPCR pattern from the placenta of embryo transfer mice demonstrated a strong expression of proinflammatory cytokines including: IL-1β, a marker for perinatal brain injury; C-X-C motif chemokine 10 (Cxcl10), a chemokine for T cells; IL-6, which elicits preterm labor; and C-C motif ligand 5 (Ccl5), a chemotactic cytokine in all groups. These expression patterns were confirmed by PCR. The WT dams and pups displayed a unique expression of signal transducer and activator of transcription 1 (Stat1) and 6 (Stat6), both proinflammatory transcription factors. The differentiating feature of the neurodevelopmentally normal DEF dams and DEF pups group was the overexpression of colony stimulating factor (Csf) 3, more than one-hundred-fold increase.
Discussion
Using a well-established mouse model of intrauterine inflammation, we are the first to report that both maternal and fetal IL-1β contribute to brain injury. Multiple lines of data implicate IL-1β as a key mediator of perinatal brain injury with exposure to intrauterine inflammation [15] . In this study, we demonstrated that blockade of IL-1β release prevented inflammation-induced fetal cortical neuronal damage as well as adverse neurobehavioral outcomes, regulated by inflammatory gene expression at the placental level.
The association between exposure to intrauterine inflammation and perinatal brain injury is well established [22, [59] [60] [61] . In rat models, blockade of IL-1 signaling with interleukin-1 receptor antagonist (IL-1RA) was shown to prevent placental damage, motor Offspring from surviving litters were tested on postnatal days (PND) 5 and 13 for performance of negative geotaxis and cliff aversion tests. Offspring exposed to prenatal LPS showed significant impairment in negative geotaxis and cliff aversion (P < 0.001 vs LPS; P < 0.05 vs LPS, generalized estimating equations). A total of 30 litters were analyzed with consideration given to litter effects (N = 6 PBS, 5 LPS, 5 BBG+PBS, and 9 BBG+LPS). The treatment with BBG ameliorates these changes. ( * P < 0.05 vs LPS, * * P < 0.01 vs LPS, * * * P < 0.001 vs LPS).
dysfunction, and neuronal injury but did not prevent preterm birth [15, 50] . However, the mechanisms by which IL-1 signaling mediates perinatal brain injury are not well elucidated.
As a central regulator of immune activation, expression of IL-1β is tightly regulated transcriptionally and post-translationally [36] [37] [38] [39] [40] . The secretion of the active, mature form of IL-1β requires activation of P2X7, a purigenic ion channel that senses extracellular ATP [41, 42] . Studies have also elucidated that the inhibition of various points in this regulated pathway attenuates the downstream inflammatory sequelae of inflammation and perinatal brain injury in utero. The inhibition of the pathway has been shown on two levels: at the IL-1β production and release or at the cellular receptor level.
Girard and colleagues [15] showed that maternal systemic administration of LPS-reduced placental perfusion evidenced by magnetic resonance imaging and increased the expression of placental proinflammatory cytokines including IL-1β, leading to reduced litter size including neurodevelopmentally delayed pups sustaining white matter brain lesions with microglial activation. The introduction of IL-1RA with concomitant maternal LPS injection led to preserved placental tissue integrity, reduced expression of pro-inflammatory cytokines, and provided a favorable survival and neurodevelopmental profile for pups [15] . Additionally, while maternal antagonism of IL-1β did not abate preterm birth, the introduction of IL-1RA prevented abnormal arborization of dendritic processes in fetal cortical neurons and, in turn, improved neuronal morphology including cell body diameter and dendritic area. The proposed mechanism implicated is IL-1RA maintaining the phosphorylation, and therefore the deactivation of neural nitric oxide synthase, an enzyme implicated in neurotoxicity.
Studies suggest that IL-1RA preserves fetal cortical morphology, ultimately attenuating the effects of LPS-induced intrauterine inflammation while leaving the essential mechanism of preterm birth unaffected [50] . The neuroinflammatory response of LPS is not limited to maternal intrauterine administration; however, as postnatal injection to neonatal rats mimics the derangements with respect to neuronal morphology and neurodevelopmental manifestations as the maternal injection. Postnatal intracerebral administration of IL-1RA with LPS improved motor behavioral deficits and prevented injury to the dopaminergic system [59] . The culmination of results suggests that LPS-mediated damage is at the cellular level with IL-1β as the predominant molecule. While the aftereffects are manifested as aberrations in behavior in early postnatal life, this adverse postnatal phenotype is largely preventable with pharmacologic blockade. At the receptor level of the inflammatory response, the P2X7 senses increased levels of ATP in the extracellular milieu from activated immune cells. This interaction sets into motion the process of further proinflammatory cytokine release through a mechanism that has yet to be determined. BBG is a dye that specifically blocks P2X7 channels, and has been shown to reduce cytokine response and confer neuroprotection in models of brain injury [42, 43, 45, 47] . Similarly to IL-1RA, BBG also inhibits microglial activation at the cellular level and is characterized by low toxicity and high selectivity [51] . In contrast, however, BBG also improves the preterm birth rate while IL-1RA has no effect on preterm birth rates shedding clinical utility on its use. In this study, we utilized both genetic and pharmacologic blockade targeting P2X7 to examine the role of IL-1β in perinatal brain injury. However, a major caveat is that in addition to apoptosis, we cannot rule out other forms of cellular damage such as autophagy and necrosis, which may also be contributing to brain injury.
In our embryo transfer studies, we observed a clear distinction between placental and fetal brain expression profiles. Globally, the placenta harbors a propensity for inflammation with an overexpression of proinflammatory cytokines and gathering other markers suggestive of a heightened adaptive immune response. The knockout pups gestating in WT dams demonstrated the most significant damage from an overwhelming Cxcl10 and Ccl5 expression. We speculate that these individual differences in the expression of proinflammatory factors among the different genotypes account for the phenotypic expression, suggesting a threshold to be reached before neurons sustain damage, ultimately leading to neurodevelopmental abnormalities. In addition, our results also purport that an intact P2X7 receptor in the dam was a prerequisite for neuronal damage after LPS exposure and may be the driving force behind neuronal damage.
Stat1 is a transcription factor involved in upregulation by interferon signaling, forming homodimers or heterodimers. The downstream pathway upregulates interferon-stimulated genes to control pathogenic infection [62] . Stat6 is a similar transcription factor involved in IL4-mediated Type 2 helper T cells cell differentiation with concomitant proliferation of humoral immunity. Interferon γ has also been shown to induce Type 1 helper T cell to B cells, promoting proliferation and maturation [62] . We propose that neuronal damage and neurodevelopmental deficiency in LPS-exposed fetuses are a product of humoral immunity upregulation, in part, from Stat1 and Stat6 overexpression at the placental level. Additionally, the altered gene expression ultimately results in morphological damage, but this also implies the existence of a conduit by which maternal response communicates with fetal response. We hypothesize the placenta acts in this role. The altered gene expression process at the placental level witnesses a highly regulated process that involves upregulation of Csf3 in the double knockout embryo transfer samples. Colony stimulating factor promotes neurogenesis and neuroplasticity. We propose that it is the substantial upregulation of Csf3 at the placental level concomitant to P2X7 knockout recues neuronal architecture and function, ultimately protecting pups from LPS exposure.
At the level of the fetal brain, we found evidence of neuroinflammation associated with white matter damage and strongly linked to cognitive and neurobehavioral disorders. The WT genotype of both dams and pups overexpressed genes important in fertilization and embryogenesis. Perhaps, this profile suggests that the genotypically normal fetus responds to inflammation by expressing genes inextricably linked to embryo formation, structure, and proliferation, the same genes that ultimately led to the ontology of the fetus.
The fetal brains derived from Dam KO Pup KO samples suggest a predisposition towards platelet aggregation, ubiquitination, and apoptosis, all designed as defense mechanisms to protect the fetal brain from further damage. We posit that this defense mechanism may explain the preserved neuronal dendrite counts and architecture in this group.
The most notable gene expression profile was derived from the fetal brains of the Dam WT Pup KO subgroup. The C03002615Rik, Ddx3y, Uty, Kdm5d, and Eif2s3y are Y-linked genes, which guide the formation of male-biased brain region formation. Our study did not select embryos based on sex and indeed the ET samples are randomized to gender. Multiple studies have studied the differential embryologic gene expression of males and females, and in our study, the male fetal brain gene expression profile drives the results. Our underlying theory is that the IL-1β produced by the dam causes the genes of the male fetal brain to become dysynchronized so much so that their essential orchestration is eradicated, inhibiting proper brain development. The extent to which this effect is seen predominantly with male fetal brains is unclear, but we presume that the Y-derived genes serve as a compensatory survival mechanism gone awry. Fetal brains of female fetuses may exhibit some equilibrating mechanism owing to their extra X chromosome. These results also may explain the higher morbidity with male fetuses as a result of preterm delivery secondary to intrauterine inflammation. This is the first study of its kind to interweave the IL-1β secretion and differential expression of cytokine signaling molecules at the level of placenta with fetal brain gene expression and neurologic outcomes. Our data provide evidence that IL-1β secretory mechanisms at the level of placenta play a key role in the propagation of perinatal brain injury. Both genetic and pharmacologic blockade of IL-1β signaling, by targeting maternal P2X7R, ameliorated perinatal brain injury following exposure to intrauterine inflammation. Specific targeting of P2X7R may provide a clinically useful tool to prevent both preterm birth and perinatal brain injury associated with exposure to intrauterine inflammation. Furthermore, future studies of pharmacologic interventions for prevention of prematurity should concentrate on specific targeting and immunomodulation at the maternal-fetal interface, with its direct effects on placenta and indirect effects on the fetus.
Supplementary data
Supplementary data are available at BIOLRE online.
Supplementary Figure 1 . Immunohistochemical representation of P2X7 receptor in placenta shows higher expression in the LPStreated group. We localized high levels of P2X7 at the chorionic plate (measurement bar: 50μm).
